United StatesBreaking News

Less than two weeks after the year's most hotly anticipated IPO, investors are questioning the remaining upside of a company that seeks to raise billions in investor-grade debt as the AI trade stalls and other major offerings from OpenAI and Anthropic loom. Bloomberg's Charlie Wells discusses on "The Pulse with Francine Lacqua."

AbbVie (NYSE:ABBV) said the European Commission has granted approval for its oral antiviral MAVIRET (glecaprevir/pibrentasvir) to treat acute hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older with compensated liver disease, with or without cirrhosis.

Ludovic Subran, chief investment officer and chief economist at Allianz, discusses the outlook for technology stocks, inflation and central bank policy. He speaks on Bloomberg Television.

Brent crude futures fell $1.09, or 1.4%, to $76.81 a barrel, while U.S. West Texas Intermediate crude declined 87 cents, or 1.2%, to $72.99 a barrel as of 0607 GMT.

Keurig Dr Pepper (NASDAQ:KDP) disclosed executive changes as it advances plans to separate its beverage and coffee businesses into two standalone companies in early 2027.

South Korean stocks tumbled from a record high as investors sold off chip heavyweights on renewed concern that the rally has become overstretched. The Kospi closed down 10%, with losses extending after a 20-minute trading suspension by the Korea Exchange. Bloomberg's Neil Campling has the latest.

AbbVie (NYSE:ABBV) secured European Commission approval for SKYRIZI to treat pediatric plaque psoriasis patients aged six and older.

Oil steadied after falling more than 3% in previous sessions following early progress in peace talks over the Iran war. A US waiver allows some sales from Iran, offering them a crucial economic lifeline. Rachel Ziemba, Founder of Ziemba Insights spoke to Bloomberg's Abeer Abu Omar on Horizons Middle East and Africa on the energy markets response to the US-Iran talks.

Anna Edwards, Guy Johnson, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

Technology stocks came under heavy selling pressure with Nasdaq 100 futures pointing to a 2.8% decline and S&P 500 futures down 1.4%.

Zerodha co-founder, Nikhil Kamath, says he's increasing exposure to Indian equities despite recent foreign outflows and muted market performance. He joined Bloomberg's Minmin Low on the sidelines of the World Economic Forum in Dalian and appeared on Insight with Haslinda Amin.

Emilie Bodoin, Founder, Chairman & CEO of Pure Lithium, discusses advances in battery technology and supply chains. The company has a pilot line launching in Chicago and is seeking partners for commercialization. She speaks on the sidelines of the World Economic Forum in Dalian with Bloomberg's Minmin Low.